$0.373
+0.0039 (+1.06%)
At Close: Jun 03, 2026
Avalon GloboCare partners with Qi Diagnostics on clinical studies of DKAir breathalyzer for diabetic ketoacidosis
09:42am, Wednesday, 18'th Oct 2023
Avalon GloboCare Corp (NASDAQ:ALBT) shares rose in early trade after it announced a partnership with medical device company Qi Diagnostics to co-develop international multi-center clinical studies for
Avalon GloboCare debuts KetoAir app on Apple App Store
10:11am, Wednesday, 04'th Oct 2023
Avalon GloboCare Corp (NASDAQ:ALBT) has officially unveiled its KetoAir mobile application on the Apple App Store. Coupled with an AI nutritionist and a nanosensor-based breathalyzer, KetoAir serves a
Apple Approves Use of Avalon GloboCare's KetoAir Mobile Application
09:00am, Wednesday, 04'th Oct 2023
KetoAir™ Mobile Application Launches in Apple App Store KetoAir™ Mobile Application also Available in the Google Play Store FREEHOLD, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Cor
Avalon GloboCare shares spike on Laboratory Services MSO acquisitions
09:51am, Wednesday, 13'th Sep 2023
Avalon GloboCare Corp (NASDAQ:ALBT) announced that its 40% owned clinical diagnostics and reference lab Laboratory Services MSO (LSM) has made two significant accretive acquisitions: Merlin Medical S
FREEHOLD, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical l
Avalon GloboCare shares surge as recent momentum continues
02:43pm, Tuesday, 05'th Sep 2023
Avalon GloboCare Corp (NASDAQ:ALBT) shares climbed 29% to $1.24 on Tuesday after the precision diagnostics and clinical laboratory services provider said it received a new US patent titled "QTY Fc F
Avalon GloboCare adds QTY Code patent to its portfolio
08:43am, Tuesday, 05'th Sep 2023
Avalon GloboCare Corp (NASDAQ:ALBT) has received a new patent to add to its portfolio. The Freehold, New Jersey-based company announced the United States Patent and Trademark Office (USPTO) issued a N
Avalon GloboCare investee LSM launches innovative lab test for tuberculosis
09:57am, Wednesday, 30'th Aug 2023
Avalon GloboCare Corp (NASDAQ:ALBT) announced that its 40% owned Laboratory Services MSO, LLC (LSM) is now offering an in-house laboratory developed test (LDT) to detect tuberculosis (TB) using a pati
Avalon's Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis
09:00am, Wednesday, 30'th Aug 2023
New Proprietary Testing Method Makes Tuberculosis Diagnosis Easier and Faster New Test Method Expected to Generate Revenue in 2023 FREEHOLD, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Co
Avalon GloboCare announces Laboratory Services MSO's expansion into Arizona
09:40am, Monday, 21'st Aug 2023
Avalon GloboCare Corp (NASDAQ:ALBT) told investors that Laboratory Services MSO (LSM), in which it owns a 40% interest, is opening a new laboratory — Veritas Laboratories — in Scottsdale, Arizona.
Avalon's Laboratory Services MSO Announces Expansion into Arizona
09:00am, Monday, 21'st Aug 2023
New Wholly Owned Lab “Veritas Laboratory” of Arizona, Anticipated to Generate Revenue in 2023 Engages Former Congressman Barry M. Goldwater Jr. To Expand Insurance Coverage and Grow Lab Footprint
Avalon GloboCare investee buys Houston-based lab testing facility
10:06am, Monday, 24'th Jul 2023
Avalon GloboCare Corp (NASDAQ:ALBT) announced that Laboratory Services MSO, in which the company holds a 40% interest, has acquired DE Laboratory LLC. The Houston-based lab expands LSM's market pene
Avalon's Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth
09:00am, Monday, 24'th Jul 2023
DE Laboratory in Texas Performs 1,500 Lab Tests Per Month with Focus on Toxicology and Wellness Testing; Expansion Underway DE Laboratory in Texas Performs 1,500 Lab Tests Per Month with Focus on Toxi
Avalon GloboCare investee LSM inks lab testing deal with GeneX
09:54am, Wednesday, 19'th Jul 2023
Avalon GloboCare Corp (NASDAQ:ALBT) announced that its 40% owned Laboratory Services MSO, LLC (LSM) has signed an exclusive master service agreement (MSA) with GeneX Laboratory Professional Corp to be
Avalon GloboCare says 2023 will be ‘pivotal year' as it executes new commercial strategy
10:09am, Monday, 10'th Jul 2023
Avalon GloboCare Corp (NASDAQ:ALBT) has updated investors on its progress in implementing its new commercial strategy focused on laboratory acquisitions and diagnostics. In a letter to shareholders,
Sign In
Buy ALBT